The antigen presentation function of bone marrow-derived mast cells is spatiotemporally restricted to a subset expressing high levels of cell surface FcεRI and MHC II

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Gong, Jian ^a   Yang, Ning Sun ^b   Croft, Michael ^c   Weng, I Chun ^d   Sun, Liangwu ^a   Liu, Fu Tong ^d   Chen, Swey Shen ^a,b,e  

^a IgE Therapeutics Inc   (United States)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC EPSILON RECEPTOR I; FC RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STEM CELL FACTOR; UNCLASSIFIED DRUG; ANTIGEN; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN E RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL SURFACE; FEMALE; MAST CELL; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; ANIMAL; BONE MARROW CELL; CELL CULTURE; CYTOLOGY; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; TIME;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; BONE MARROW CELLS; CELLS, CULTURED; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTRACELLULAR SPACE; MAST CELLS; MICE; RECEPTORS, IGE; TIME FACTORS;

EID: 77954070293     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-34     Document Type: Article

References (35)

1. Galli S, Tsai M, Piliponsky A. The development of allergic inflammation. Nature 2008, 454:445-454. 10.1038/nature07204, 18650915.
2. Yu M, Tsai M, Tam S, Jones C, Zehnder J, Galli S. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 2006, 116:1633-1641. 10.1172/JCI25702, 1462940, 16710480.
3. Malaviya R, Ross E, Jakschik BA, Abraham SN. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J Clin Invest 1994, 93:1645-1653. 10.1172/JCI117146, 294203, 7512987.
4. Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996, 381:75-77. 10.1038/381075a0, 8609992.
5. Nakano T, Sonoda T, Hayashi C, Yamatodani A, Kanayama Y, Yamamura T, Asai H, Yonezawa T, Kitamura Y, Galli SJ. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell- deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 1985, 162:1025-1043. 10.1084/jem.162.3.1025, 2187813, 3897446.
6. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 1989, 7:59-76. 10.1146/annurev.iy.07.040189.000423, 2653378.
7. Tsai M, Shih LS, Newlands GF, Takeishi T, Langley KE, Zsebo KM, Miller HR, Geissler EN, Galli SJ. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 1991, 174:125-131. 10.1084/jem.174.1.125, 2118877, 1711559.
8. Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 1996, 156:1490-1496.
9. Frandji P, Mourad W, Tkaczyk C, Singer M, David B, Colle JH, Mecheri S. IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway. Eur J Immunol 1998, 28:844-854. 10.1002/(SICI)1521-4141(199803)28:03<844::AID-IMMU844>3.0.CO;2-4, 9541579.
10. Chen S, Cerny J. Studies on hapten-specific B cell tolerance in vitro. I. The inductive phase of central B cell tolerance. J Immunol 1980, 125:1962-1969.
11. Hirsch S, Austyn JM, Gordon S. Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture. J Exp Med 1981, 154:713-725. 10.1084/jem.154.3.713, 2186468, 7276827.
12. Yen A, Liu FT, Barrett KE, Gigli I. Alterations in Fc epsilon RI induced by protoporphyrin plus long-wavelength ultraviolet light in mouse bone marrow-derived mast cells. J Immunol 1993, 151:1003-1011.
13. Ryan JJ, Huang H, McReynolds LJ, Shelburne C, Hu-Li J, Huff TF, Paul WE. Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells. Exp Hematol 1997, 25:357-362.
14. Razin E, Mencia Huerta JM, Stevens RL, Lewis RA, Liu FT, Corey E, Austen KF. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med 1983, 157:189-201. 10.1084/jem.157.1.189, 2186907, 6184439.
15. Tanaka S, Deai K, Inagaki M, Ichikawa A. Uptake of histamine by mouse peritoneal macrophages and a macrophage cell line, RAW264.7. Am J Physiol Cell Physiol 2003, 285:C592-598.
16. Dvorak A, Seder R, Paul W, Morgan E, Galli S. Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro. Am J Pathol 1994, 144:160-170. 1887107, 7507298.
17. Dubey C, Croft M, Swain SL. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol 1995, 155:45-57.
18. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci 1999, 96:8080-8085. 10.1073/pnas.96.14.8080, 22191, 10393951.
19. Frandji P, Oskeritzian C, Cacaraci F, Lapeyre J, Peronet R, David B, Guillet JG, Mecheri S. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 1993, 151:6318-6328.
20. Levi-Schaffer F, Dayton ET, Austen KF, Hein A, Caulfield JP, Gravallese PM, Liu FT, Stevens RL. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2. J Immunol 1987, 139:3431-3441.
21. Karasuyama H, Mukai K, Tsujimura Y, Obata K. Newly discovered roles for basophils: a neglected minority gains new respect. Nat Rev Immunol 2009, 9:9-13. 10.1038/nri2458, 19039320.
22. Kojima T, Obata, Kazushige, Mukai, Kaori, Sato, Shingo, Takai, Toshiyuki, Minegishi, Yoshiyuki, Karasuyama, Hajime. Mast Cells and Basophils Are Selectively Activated In Vitro and In Vivo through CD200R3 in an IgE-Independent Manner. J Immunol 2007, 179:7093-7100.
23. Edward F, Knol A. Editorial: Basophil survival and immunomodulatory function are uniquely regulated by a novel MyD88-dependent pathway. J Leukoc Biol 2009, 86:753-755. 10.1189/jlb.0409248, 19797302.
24. Sullivan B, Locksley RM. Basophils: a nonredundant contributor to host immunity. Immunity 2009, 30:12-20. 10.1016/j.immuni.2008.12.006, 19144314.
25. Ryan JJ, Kinzer CA, Paul WE. Mast cells lacking the high affinity immunoglobulin E receptor are deficient in Fc epsilon RI gamma messenger RNA. J Exp Med 1995, 182:567-574. 10.1084/jem.182.2.567, 2192112, 7629513.
26. Kinzer CA, Keegan AD, Paul WE. Identification of Fc epsilon RIneg mast cells in mouse bone marrow cell cultures. Use of a monoclonal anti-p161 antibody. J Exp Med 1995, 182:575-579. 10.1084/jem.182.2.575, 2192123, 7629514.
27. Schmaltz R, Wang Y-Y, Kung Q-X, Liu F-T, Petro T, Chen S-S. B cell hybridoma presents both B-cell and T-cell epitopes for stimulating antibody production via CD23 pathway. Immunol Invest 1996, 25(5-6):481-493. 10.3109/08820139609055737, 8915685.
28. Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8:478-486. 10.1038/nri2327, 2855166, 18483499.
29. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007, 8:1095-1104. 10.1038/ni1503, 17767162.
30. Lu L-F, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, Scott ZA, Coyle AJ, Reed JL, Van Snick J, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006, 442:997-1002. 10.1038/nature05010, 16921386.
31. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C. Accumulation of Major Histocompatibility Complex Class II Molecules in Mast Cell Secretory Granules and Their Release upon Degranulation. Molecular Biology of the Cell 1997, 8:2631-2645. 25733, 9398681.
32. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, Pain S, Raposo G, Benaroch P, Bonnerot C. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol 2002, 14:713-722. 10.1093/intimm/dxf048, 12096030.
33. Skokos D, Botros HG, Demeure C, Morin J, Peronet R, Birkenmeier G, Boudaly S, Mecheri S. Mast Cell-Derived Exosomes Induce Phenotypic and Functional Maturation of Dendritic Cells and Elicit Specific Immune Responses In Vivo. J Immunol 2003, 170:3037-3045.
34. Wynn TA. Basophils trump dendritic cells as APCs for TH2 responses. Nat Immunol 2009, 10:679-681. 10.1038/ni0709-679, 2756226, 19536189.
35. Kalesnikoff J, Galli S. New developments in mast cell biology. Nat Immunol 2008, 9:1215-1223. 10.1038/ni.f.216, 2856637, 18936782.